Skip to main content
Medical information Clinical review pending

Genetic Testing

ABCA1 Gene HDL Deficiency Type 2 Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to identify variations in the ABCA1 gene associated with HDL deficiency, a metabolic disorder. Helps understand genetic predisposition and manage cardiovascular risk.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample.
Results
Approximately 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
A clinical history of the patient is required. A genetic counseling session to draw a pedigree chart of family members affected with HDL deficiency, type 2, is recommended before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the ABCA1 Gene HDL Deficiency Type 2 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of HDL deficiency.
  • ✓Family history of related metabolic disorders.
  • ✓Low levels of HDL cholesterol.
  • ✓Increased risk of cardiovascular diseases.
  • ✓Personal history suggestive of HDL deficiency.
02

In plain language

What this test helps you understand

Identifies genetic variations in the ABCA1 gene associated with HDL deficiency, aiding in the diagnosis and understanding of this metabolic disorder and its potential impact on cardiovascular health.
The ABCA1 Gene HDL Deficiency Type 2 NGS Genetic DNA Test is a diagnostic tool used to identify genetic factors linked to HDL (High-Density Lipoprotein) deficiency. This condition is a significant metabolic disorder. The test employs Next-Generation Sequencing (NGS) technology to analyze the ABCA1 gene, which is important for lipid metabolism and cardiovascular health. Understanding your genetic predisposition can help you and your doctor make informed decisions about managing your health. This test specifically looks for variations in the ABCA1 gene that may cause HDL deficiency. Identifying these genetic changes can help healthcare providers understand the risk of related metabolic disorders and cardiovascular diseases. Results will indicate the presence of specific genetic mutations. A healthcare provider will interpret these results and discuss potential implications and next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history of the patient is required. A genetic counseling session to draw a pedigree chart of family members affected with HDL deficiency, type 2, is recommended before booking.
SampleBlood sample.
MethodologyNext-Generation Sequencing (NGS) of the ABCA1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies specific variations in the ABCA1 gene. It may not detect all possible genetic causes of HDL deficiency. Results should be interpreted by a qualified healthcare professional in the context of the patient's clinical history and other relevant tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

HDL (High-Density Lipoprotein) deficiency is a metabolic disorder characterized by low levels of HDL cholesterol, often referred to as 'good' cholesterol. It can increase the risk of cardiovascular diseases.
Individuals with a family history of HDL deficiency, low HDL cholesterol levels, or related metabolic disorders should discuss this test with their doctor.
The test requires a blood sample. A clinical history and potentially a genetic counseling session are recommended prior to testing.
A healthcare provider will interpret the results, explaining the presence or absence of specific genetic variations in the ABCA1 gene and their potential implications for your health.
We have branches in Nairobi, Mombasa, and Kisumu, and offer a home sample collection service. Please contact us to confirm availability in your area.
The current price for the ABCA1 Gene HDL Deficiency Type 2 NGS Genetic DNA Test is 40,000 KSh. Please confirm pricing before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp